Evidence map›Paper›PMID 34520182›Full record

ArticleACS applied materials & interfaces2021

In Search of Effective UiO-66 Metal-Organic Frameworks for Artificial Kidney Application.

Klaudia Dymek, Grzegorz Kurowski, Łukasz Kuterasiński, Roman Jędrzejczyk, Magdalena Szumera, Maciej Sitarz, Anna Pajdak, Łukasz Kurach, Anna Boguszewska-Czubara, Przemysław J Jodłowski

Open access · hybridAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. The MOF-Microbiome Axis: a New Paradigm for Precision Nanomedicine.Probiotics and antimicrobial proteins · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Klaudia DymekFaculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 30-155 Kraków, Poland.
Grzegorz KurowskiFaculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 30-155 Kraków, Poland.
Łukasz KuterasińskiJerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, 30-239 Kraków, Poland.
Roman JędrzejczykMałopolska Centre of Biotechnology, Jagiellonian University, ul. Gronostajowa 7A, 30-387 Kraków, Poland.
Magdalena SzumeraFaculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza 30, 30-059 Kraków, Poland.
Maciej SitarzFaculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza 30, 30-059 Kraków, Poland.ORCID https://orcid.org/0000-0002-8339-2710
Anna PajdakStrata Mechanics Research Institute, Polish Academy of Sciences, Reymonta 27, 30-059 Kraków, Poland.
Łukasz KurachIndependent Laboratory of Behavioral Studies, Medical University of Lublin, 4A Chodzki Str., 20-093 Lublin, Poland.ORCID https://orcid.org/0000-0002-1005-8068
Anna Boguszewska-CzubaraDepartment of Medical Chemistry, Medical University of Lublin, 4A Chodzki Str., 20-093 Lublin, Poland.
Przemysław J JodłowskiFaculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 30-155 Kraków, Poland.ORCID https://orcid.org/0000-0003-2554-6539
Cracow University of Technology · PLAGH University of Krakow · PLMedical University of Lublin · PLJagiellonian University · PLJerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences · PLStrata Mechanics Research Institute · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The removal of uremic toxins from patients with acute kidney injury is a key issue in improving the quality of life for people requiring peritoneal dialysis. The currently utilized method for the removal of uremic toxins from the human organism is hemodialysis, performed on semipermeable membranes where the uremic toxins, along with small molecules, are separated from proteins and blood cells. In this study, we describe a mixed-linker modulated synthesis of zirconium-based metal-organic frameworks for efficient removal of uremic toxins. We determined that the efficient adsorption of uremic toxins is achieved by optimizing the ratio between -amino functionalization of the UiO-66 structure with 75% of -NH

Indexed as

Kidneys, ArtificialAdsorptionAnimalsChlorocebus aethiopsErythrocytesHEK293 CellsHippuratesHumansIndoleacetic AcidsMetal-Organic FrameworksPhthalic AcidsUremic ToxinsVero CellsZirconiumHippurateshippuric acidindoleacetic acidIndoleacetic AcidsMetal-Organic FrameworksPhthalic AcidsUiO-66Uremic ToxinsZirconiumadsorptionmetal−organic frameworksUiO-66UiO-66-NH2uremic toxins

Identifiers

PMID34520182
PMCPMC8485328
OpenAlexW3201319532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.